FDA Advisers Meet to Discuss Pfizer’s COVID-19 Pill

The Antimicrobial Drugs Advisory Committee, which advises the U.S. Food and Drug Administration, meets at 9 a.m. ET on March 16 to discuss a new application for Pfizer’s Paxlovid pill for oral use. The pill treats mild-to-moderate COVID-19 in adults who are at high risk for progression to severe COVID 19, including hospitalization or death.